This inventor holds 1 USPTO granted patent. Top assignees: Amgen Inc., Ucb S.a.. Active years: 2011.
Company Filing History:
1 out of 2,065 
1 out of 119 
Years Active: 2011
Title: Christpher Paszty: Innovator in Sclerostin Research
Introduction
Christpher Paszty is a notable inventor based in Ventura, CA. He has made significant contributions to the field of biotechnology, particularly in the study of sclerostin protein. His innovative work has led to the development of valuable compositions and methods that have implications in medical research and treatment.
Latest Patents
Christpher Paszty holds 1 patent related to sclerostin. His patent, titled "Sclerostin epitopes - Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents," focuses on antibodies capable of binding to sclerostin. This research is crucial for advancing therapeutic strategies targeting bone density and related conditions.
Career Highlights
Throughout his career, Paszty has worked with prominent companies in the biotechnology sector. He has been associated with UCB S.A. and Amgen Inc., where he has contributed to various research initiatives. His expertise in sclerostin has positioned him as a key figure in the development of innovative treatments.
Collaborations
Paszty has collaborated with esteemed colleagues, including Alistair James Henry and John A. Latham. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.
Conclusion
Christpher Paszty's work in the field of sclerostin research exemplifies the impact of innovation in biotechnology. His contributions continue to influence the development of new medical therapies, showcasing the importance of research in improving health outcomes.